Vascular Surgery Unit, University Hospital Virgen de las Nieves, Granada, Spain; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
Department of Vascular and Endovascular Surgery, Asklepios Clinic Wandsbek, Asklepios Medical School, Hamburg, Germany.
Eur J Vasc Endovasc Surg. 2023 Nov;66(5):653-660. doi: 10.1016/j.ejvs.2023.07.029. Epub 2023 Jul 23.
The need for open surgical conversion (OSC) after failed endovascular aortic aneurysm repair (EVAR) persists, despite expanding endovascular options for secondary intervention. The VASCUNExplanT project collected international data to identify risk factors for failed EVAR, as well as OSC outcomes. This retrospective cross sectional study analysed data after OSC for failed EVAR from the VASCUNET international collaboration.
VASCUNET queried registries from its 28 member countries, and 17 collaborated with data from patients who underwent OSC (2005 - 2020). Any OSC for infection was excluded. Data included demographics, EVAR, and OSC procedural details, as well as post-operative mortality and complication rates.
There were 348 OSC patients from 17 centres, of whom 33 (9.4%) were women. There were 130 (37.4%) devices originally deployed outside of instructions for use. The most common indication for OSC was endoleak (n = 143, 41.1%); ruptures accounted for 17.2% of cases. The median time from EVAR to OSC was 48.6 months [IQR 29.7, 71.6]; median abdominal aortic aneurysm diameter at OSC was 70.5 mm [IQR 61, 82]. A total of 160 (45.6%) patients underwent one or more re-interventions prior to OSC, while 63 patients (18.1%) underwent more than one re-intervention (range 1 - 5). Overall, the 30 day mortality rate post-OSC was 11.8% (n = 41), 11.1% for men and 18.2% for women (p = .23). The 30 day mortality rate was 6.1% for elective cases, and 28.3% for ruptures (p < .0001). The predicted 90 day survival for the entire cohort was 88.3% (95% CI 84.3 - 91.3). Multivariable analysis revealed rupture (OR 4.23; 95% CI 2.05 - 8.75; p < .0001) and total graft explantation (OR 2.10; 95% CI 1.02 - 4.34; p = .04) as the only statistically significant predictive factors for 30 day death.
This multicentre analysis of patients who underwent OSC shows that, despite varying case mix and operative techniques, OSC is feasible but associated with significant morbidity and mortality rates, particularly when performed for rupture.
尽管血管内治疗选择不断扩大,但在血管内修复失败后仍需要进行开放手术转换(OSC)。VASCUNExplanT 项目收集了国际数据,以确定血管内修复失败的风险因素以及 OSC 的结果。这项回顾性横断面研究分析了来自 VASCUNET 国际合作的血管内修复失败后 OSC 的数据。
VASCUNET 从其 28 个成员国的登记处查询,并与 17 个成员国的数据进行合作,这些成员国的患者接受了 OSC(2005-2020 年)。任何因感染而进行的 OSC 均被排除在外。数据包括人口统计学、血管内修复和 OSC 手术细节,以及术后死亡率和并发症发生率。
17 个中心的 348 名 OSC 患者中,有 33 名(9.4%)为女性。最初有 130 名患者(37.4%)使用了超出使用说明的设备。OSC 的最常见指征是内漏(n=143,41.1%);破裂占病例的 17.2%。血管内修复与 OSC 之间的中位时间为 48.6 个月[IQR 29.7,71.6];OSC 时的中位腹主动脉瘤直径为 70.5 毫米[IQR 61,82]。共有 160 名患者(45.6%)在 OSC 之前进行了一次或多次再介入,而 63 名患者(18.1%)进行了多次再介入(范围 1-5)。总体而言,OSC 后 30 天死亡率为 11.8%(n=41),男性为 11.1%,女性为 18.2%(p=0.23)。择期病例的 30 天死亡率为 6.1%,破裂病例为 28.3%(p<0.0001)。整个队列的 90 天预测生存率为 88.3%(95%CI 84.3-91.3)。多变量分析显示破裂(OR 4.23;95%CI 2.05-8.75;p<0.0001)和总移植物取出(OR 2.10;95%CI 1.02-4.34;p=0.04)是 30 天死亡的唯一统计学显著预测因素。
这项对接受 OSC 患者的多中心分析表明,尽管病例组合和手术技术各不相同,但 OSC 是可行的,但与高发病率和死亡率相关,尤其是在破裂时进行时。